Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice

Tomás José González-López, Nuria Bermejo-Vega, Rocío Cardesa-Cabrera, Violeta Martínez-Robles, Gerardo Aguilar-Monserrate, Gloria Pérez-Segura, Abel Domingo, Josefa Luis-Navarro, Sunil Lakhwani, Natalia Acedo, María Luisa Lozano, Silvia Bernat, Ana Torres-Tienza, Ana Ruano, Isidro Jarque, Pilar Galán, Carmen Benet, Shally Marcellini, Reyes Jimenez-Bárcenas, Daniel Martínez-Carballeira, Dunia De Miguel-Llorente, Alvaro Perona-Blázquez, Isabel Gonzalez-Gascón, Elsa Lopez-Ansoar, José María Alonso-Alonso, María Luisa Bengochea-Casado, Francisco Javier Díaz-Gálvez, Ana Moretó, Gemma Moreno-Jiménez, Roberto Hernández-Martin, Erik de Cabo, Julio Dávila-Valls, Amalia Cuesta, Carmen Pastoriza, Gerardo Julio Hermida-Fernández, Covadonga García, Miguel Angel Pozas-Mañas, Carlos Aguilar, Dolores Fernandez-Jimenez, Begoña Navas-Elorza, Carolina López-Santamaría Castro, Alvaro Lorenzo, Xavier Ortín, Marta García, Sonia Piernas, Johana Díaz-Santa, Inmaculada Soto, Drew Provan, Gloria García-Donas Gabaldón

Blood (2024) 144 (6): 646–656.

https://doi.org/10.1182/blood.2024024250

Published: 2024

Journal Articles

The Lack of Tolerable Treatments Options That Can Induce Durable Responses without Fear of Relapse after Discontinuation Represents a Significant Unmet Need for Patients (Pts) with Immune Thrombocytopenia (ITP): Results from the ITP World Impact Survey (I-WISh) 2.0

James B. Bussel, Nichola Cooper, Waleed Ghanima, Drew Provan, Yoshiaki Tomiyama, Ming Hou, Donald Arnold, Cristina Santoro, Francesco Zaja, Barbara Lovrencic, Mervyn Morgan, Leron Lahav, Michal Winograd, Jennifer MacWhirter - DiRaimo, Tom Bailey, Moyra Aziz, Roberto Abi Rached, Caroline Kruse

Blood (2023) 142 (Supplement 1): 1212.

https://doi.org/10.1182/blood-2023-188527

Published: 2023

Journal Articles

ITP World Impact Survey (I-WISh) 2.0: Further Exploration of the Impact of ITP on Patients

Waleed Ghanima, Drew Provan, Nichola Cooper, MD, Axel Matzdorff, MDPhD, Ming Hou, Cristina Santoro, Mervyn Morgan, Caroline Kruse, Francesco Zaja, Leron Lahav, Yoshiaki Tomiyama, Michal Winograd, Barbara Lovrencic, Tom Bailey, MSci, Jens Haenig, James B. Bussel

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-136651

Published: 2020

Journal Articles

Physicians' and Patients' Perspectives on Treatments in ITP - a Multi-Country Perspective: Results from the ITP World Impact Survey (I-WISh)

James B. Bussel, MD, Waleed Ghanima, MD PhD, Yoshiaki Tomiyama, MD, Donald M. Arnold, MD, Drew Provan, MD, Ming Hou, MD PhD, Cristina Santoro, MD PhD, Serge Laborde, Alexandra Kruse, Caroline Kruse, Mervyn Morgan, Barbara Lovrencic, John Waller, PhD, Jens Haenig, Nichola Cooper, MD MRCP

Blood (2019) 134 (Supplement_1): 1097.

https://doi.org/10.1182/blood-2019-130591

Published: 2019

Journal Articles

The Psychometric Properties of the ITP Life Quality Index Assessed in a Large Multinational "Real-World" Cohort of Immune Thrombocytopaenia Patients

Philip Griffiths, Laura Grant, Nicola Bonner, MSc, Denise D'Alessio, MBA, Quentin A. Hill, Drew Provan, MD, Waleed Ghanima, MD PhD, Nichola Cooper, MD MRCP, Ricardo Viana, PhD

Blood (2019) 134 (Supplement_1): 386.

https://doi.org/10.1182/blood-2019-125766

Published: 2019

Journal Articles

International consensus report on the investigation and management of primary immune thrombocytopenia

Blood (2010) 115 (2): 168–186.

https://doi.org/10.1182/blood-2009-06-225565

Published: 2010

Includes: Supplemental data

Journal Articles

Disease Progression, Treatment Effectiveness, and Co-Morbid Burden Among Adult Patients with Primary Immune Thrombocytopenia (ITP): Results From the United Kingdom Registry.

Ameet Sarpatwari, M.Phil, Dimitri Bennett, MD, MPH, Adrian Newland, MD, FRCP, Simon Sanderson, MD, Drew Provan, MD

Blood (2009) 114 (22): 4457.

https://doi.org/10.1182/blood.V114.22.4457.4457

Published: 2009

Journal Articles

Autologous 111 In-Labeled Platelet Sequestration Studies in Patients with Primary Immune Thrombocytopenia (ITP): A Report From the United Kingdom Registry.

Ameet Sarpatwari, M.Phil, Drew Provan, MD, Ravin Sobnack, PhD, Sebhat Erqou, MD, M.Phil, F. W. David Tai, BSc., Simon Sanderson, MD, Adrian Newland, MD, FRCP

Blood (2009) 114 (22): 2406.

https://doi.org/10.1182/blood.V114.22.2406.2406

Published: 2009

Journal Articles

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

Blood (2009) 113 (11): 2386–2393.

https://doi.org/10.1182/blood-2008-07-162503

Published: 2009

Journal Articles

Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review

Roberto Stasi, Ameet Sarpatwari, Jodi B. Segal, John Osborn, Maria Laura Evangelista, Nichola Cooper, Drew Provan, Adrian Newland, Sergio Amadori, James B. Bussel

Blood (2009) 113 (6): 1231–1240.

https://doi.org/10.1182/blood-2008-07-167155

Published: 2009

Journal Articles

Health-Related Lifestyle among Adult & Pediatric Patients with Idiopathic Thrombocytopenic Purpura in the United Kingdom.

Ameet Sarpatwari, MPhil, Shirley Watson, Howard Anderson, Drew Provan, MD, Adrian Newland, MD, FRCP

Blood (2008) 112 (11): 3435.

https://doi.org/10.1182/blood.V112.11.3435.3435

Published: 2008

Journal Articles

Thromboembolic Events among Adult Patients with Idiopathic Thrombocytopenic Purpura in the United Kingdom General Practice Research Database.

Ameet Sarpatwari, MPhil, Dimitri Bennett, MD, MPH, John W Logie, PhD, Amit Shukla, BSc, Kathleen J Beach, MD, MPH, Adrian Newland, MD, FRCP, Simon Sanderson, MD, Drew Provan, MD

Blood (2008) 112 (11): 3401.

https://doi.org/10.1182/blood.V112.11.3401.3401

Published: 2008

Journal Articles

Safety of Eltrombopag, an Oral Non-Peptide Platelet Growth Factor, in the Treatment of Thrombocytopenia: Results of Four Randomized, Placebo-Controlled Studies

James B. Bussel, MD, John McHutchison, MD, Drew Provan, MD, A. Jagiello-Gruzfeld, MD, Rezvan Rafi, Sophia Goodison

Blood (2007) 110 (11): 1299.

https://doi.org/10.1182/blood.V110.11.1299.1299

Published: 2007

Journal Articles

Assessment of Bleeding in Thrombocytopenic Patients (pts) with Immune Thrombocytopenic Purpura (ITP).

Lemke K. Page, MD, Andrew S. Elish, Drew Provan, MD, Steven Myrint, MD, Michael Hamilton, MD, Julian Jenkins, MS, James B. Bussel, MD

Blood (2005) 106 (11): 1255.

https://doi.org/10.1182/blood.V106.11.1255.1255

Published: 2005

Journal Articles

Comparison of rHuEpo plus rHuG-CSF and supportive care: apples to oranges

Roberto Stasi, Sergio Amadori, Adrian C. Newland, Drew Provan

Blood (2004) 104 (7): 2201–2202.

https://doi.org/10.1182/blood-2004-04-1334

Published: 2004

Journal Articles

Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events

Surinder S. Sahota, Francesco Forconi, Christian H. Ottensmeier, Drew Provan, David G. Oscier, Terry J. Hamblin, Freda K. Stevenson

Blood (2002) 100 (4): 1505–1507.

https://doi.org/10.1182/blood.V100.4.1505.h81602001505_1505_1507

Published: 2002

NARROW

Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice

The Lack of Tolerable Treatments Options That Can Induce Durable Responses without Fear of Relapse after Discontinuation Represents a Significant Unmet Need for Patients (Pts) with Immune Thrombocytopenia (ITP): Results from the ITP World Impact Survey (I-WISh) 2.0

ITP World Impact Survey (I-WISh) 2.0: Further Exploration of the Impact of ITP on Patients

Physicians' and Patients' Perspectives on Treatments in ITP - a Multi-Country Perspective: Results from the ITP World Impact Survey (I-WISh)

The Psychometric Properties of the ITP Life Quality Index Assessed in a Large Multinational "Real-World" Cohort of Immune Thrombocytopaenia Patients

International consensus report on the investigation and management of primary immune thrombocytopenia

Disease Progression, Treatment Effectiveness, and Co-Morbid Burden Among Adult Patients with Primary Immune Thrombocytopenia (ITP): Results From the United Kingdom Registry.

Autologous 111 In-Labeled Platelet Sequestration Studies in Patients with Primary Immune Thrombocytopenia (ITP): A Report From the United Kingdom Registry.

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review

Health-Related Lifestyle among Adult & Pediatric Patients with Idiopathic Thrombocytopenic Purpura in the United Kingdom.

Thromboembolic Events among Adult Patients with Idiopathic Thrombocytopenic Purpura in the United Kingdom General Practice Research Database.

Safety of Eltrombopag, an Oral Non-Peptide Platelet Growth Factor, in the Treatment of Thrombocytopenia: Results of Four Randomized, Placebo-Controlled Studies

Assessment of Bleeding in Thrombocytopenic Patients (pts) with Immune Thrombocytopenic Purpura (ITP).

Comparison of rHuEpo plus rHuG-CSF and supportive care: apples to oranges

Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only